Randomized controlled trial to evaluate the effectiveness of immunotherapy in gastric cancer based on preoperative serum glycoproteins: acute phase reactants (APRs).
Not Applicable
- Conditions
- Gastric cancer
- Registration Number
- JPRN-UMIN000037472
- Lead Sponsor
- Preoperative Serum Glycoproteins Study Group for Immunotherapy in Japan
- Brief Summary
PSK therapy has a beneficial effect on gastric cancer patients with high levels of CEA and acute phase reactant (APR).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 886
Inclusion Criteria
Not provided
Exclusion Criteria
1. Double cancer. 2. Prior cytotoxic or radiation therapy. 3. Abnormal bone marrow, hepatic and renal function 4. Severe cardiac, hepatic and lung failure, and an attending doctor was considered unsuitable.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method